PRINTER'S NO. 924
No. 803 Session of 1985
INTRODUCED BY WILT, WILLIAMS, PETERSON, O'CONNELL AND EARLY,
APRIL 25, 1985
REFERRED TO PUBLIC HEALTH AND WELFARE, APRIL 25, 1985
AN ACT
1 Amending the act of April 14, 1972 (P.L.233, No.64), entitled
2 "An act relating to the manufacture, sale and possession of
3 controlled substances, other drugs, devices and cosmetics;
4 conferring powers on the courts and the secretary and
5 Department of Health, and a newly created Pennsylvania Drug,
6 Device and Cosmetic Board; establishing schedules of
7 controlled substances; providing penalties; requiring
8 registration of persons engaged in the drug trade and for the
9 revocation or suspension of certain licenses and
10 registrations; and repealing an act," adding the substance
11 buprenorphine to Schedule V.
12 The General Assembly of the Commonwealth of Pennsylvania
13 hereby enacts as follows:
14 Section 1. Section 4(5) of the act of April 14, 1972
15 (P.L.233, No.64), known as The Controlled Substance, Drug,
16 Device and Cosmetic Act, is amended by adding a subclause to
17 read:
18 Section 4. Schedules of Controlled Substances.--The
19 following schedules include the controlled substances listed or
20 to be listed by whatever official name, common or usual name,
21 chemical name, or trade name designated.
22 * * *
1 (5) Schedule V--In determining that a substance comes within
2 this schedule, the secretary shall find: a low potential for
3 abuse relative to the substances listed in Schedule IV;
4 currently accepted medical use in the United States; and limited
5 physical dependence and/or psychological dependence liability
6 relative to the substances listed in Schedule IV. The following
7 controlled substances are included in this schedule:
8 * * *
9 (ii) Buprenorphine.
10 Section 2. This act shall take effect immediately.
D16L35RAW/19850S0803B0924 - 2 -